[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 Full] [EX-99.1 2]
[Youku Tudou Announces Fourth Quarter and Fiscal Year 2013 Unaudited Financial Results Achieved Quarterly Non-GAAP Profitability; Mobile Monetization Reached 10% BEIJING , China, February 28, 201 4 Youku Tudou Inc. (NYSE: YOKU, and formerly Youku Inc. or Youku ), Chinas leading Internet television company (Youku Tudou or the Company) , today announced its unaudited financial results for fourth quarter] [YOUKU TUDOU INC. 11/F, SinoSteel Plaza , 8 Haidian Street Beijing 100080 , Peoples Republic of China Form 20-F x Form 40-F o o o Yes o No x YOUKU TUDOU INC.]
[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 Full] [EX-99.1 2]
[March 3 , 201 4 Jennifer Thompson, Accounting Branch Chief Sondra Snyder, Staff Accountant Andrew Blume, Staff Accountant Division of Corporate Finance 100 F Street, NE Re: Lentuo International Inc. Form 20-F for Fiscal Year Ended December 31, 2012 File No. 001-34987 Dear Ms. Thompson, Ms. Snyder and Mr. Blume: I refer to your letter to Mr. Hetong Guo, dated]
[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China March 3, 2014 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]
